The PERU Clinical Trials Unit

The PERU CTU led by Dr. Jorge Sanchez (based at CITBM) and Dr. Alberto La Rosa (based at IMPACTA), and supported by a cadre of experienced researchers and promising junior investigators., consolidated a three-dimensional matrix organization to support the increasing number and complexity of studies from multiple HIV/AIDS clinical trial networks, and has effectively utilized its intellectual and structural resources to create and update innovative tools for more efficient operations. The PERU CTU proposes to continue efficient and ethical implementation of the clinical research agenda of the HIV Prevention Trials Network (HPTN), HIV Vaccine Trials Network (HVTN), and AIDS Clinical Trials Group (ACTG), at four Clinical Research Sites (CRSs) in Lima (Barranco, CITBM, San Miguel and Via Libre), and one CRS in Iquitos